TAAR1 and depressive disorder: Intracerebroventricular administration of 3-MT increases behavioral activity (Nakazato and Akiyama, 2002; Sotnikova et al., 2010), and 3-MT and phenylethylamine have affinity for trace amine-associated receptor 1, which is involved in neuropsychiatric disorders including depression (Shi et al., 2016).